Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jehan Dupuis

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Journal of Clinical Oncology

English

Durable Response With Single-Agent Acalabrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

English

Real-World Results of Ibrutinib in Relapsed/Refractory CLL in France: Early Results on a Large Series of 428 Patients

American Journal of Hematology

Hematology

2017

English

Efficacy of Chemotherapy or Chemo-Anti-Pd-1 Combination After Failed Anti-Pd-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Series From Lysa Centers

American Journal of Hematology

Hematology

2018

English

Optimal Oncologic Management and mTOR Inhibitor Introduction Are Safe and Improve Survival in Kidney and Liver Allograft Recipients With De Novo Carcinoma

International Journal of Cancer

Cancer Research

Oncology

2018

English

Bendamustine Plus Rituximab in Newly‐diagnosed Waldenström Macroglobulinaemia Patients. A Study on Behalf of the French Innovative Leukaemia Organization (FILO)

British Journal of Haematology

Hematology

2018

English

Transformed Waldenström Macroglobulinaemia: Clinical Presentation and Outcome. A Multi-Institutional Retrospective Study of 77 Cases From the French Innovative Leukemia Organization (FILO)

British Journal of Haematology

Hematology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jehan Dupuis

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Durable Response With Single-Agent Acalabrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Real-World Results of Ibrutinib in Relapsed/Refractory CLL in France: Early Results on a Large Series of 428 Patients

Efficacy of Chemotherapy or Chemo-Anti-Pd-1 Combination After Failed Anti-Pd-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Series From Lysa Centers

Optimal Oncologic Management and mTOR Inhibitor Introduction Are Safe and Improve Survival in Kidney and Liver Allograft Recipients With De Novo Carcinoma

Bendamustine Plus Rituximab in Newly‐diagnosed Waldenström Macroglobulinaemia Patients. A Study on Behalf of the French Innovative Leukaemia Organization (FILO)

Transformed Waldenström Macroglobulinaemia: Clinical Presentation and Outcome. A Multi-Institutional Retrospective Study of 77 Cases From the French Innovative Leukemia Organization (FILO)